State of Wisconsin Investment Board reduced its position in Amsurg Corp. (NASDAQ:AMSG) by 70.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,136 shares of the company’s stock after selling 132,276 shares during the period. State of Wisconsin Investment Board owned approximately 0.10% of Amsurg Corp. worth $3,697,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of AMSG. Wells Fargo & Company MN raised its position in shares of Amsurg Corp. by 20.7% in the third quarter. Wells Fargo & Company MN now owns 1,431,663 shares of the company’s stock worth $95,993,000 after buying an additional 245,301 shares in the last quarter. Virginia Retirement Systems ET AL bought a new position in shares of Amsurg Corp. during the third quarter worth $523,000. Capital Fund Management S.A. raised its position in shares of Amsurg Corp. by 59.9% in the third quarter. Capital Fund Management S.A. now owns 15,409 shares of the company’s stock worth $1,033,000 after buying an additional 5,775 shares in the last quarter. Rockefeller Financial Services Inc. bought a new position in shares of Amsurg Corp. during the third quarter worth $106,000. Finally, World Asset Management Inc raised its position in shares of Amsurg Corp. by 35.7% in the third quarter. World Asset Management Inc now owns 3,568 shares of the company’s stock worth $239,000 after buying an additional 939 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Institutional Ownership by Quarter for Amsurg Corp. (NASDAQ:AMSG)

Amsurg Corp. (NASDAQ:AMSG) traded up 3.85% on Tuesday, reaching $67.38. 2,074,132 shares of the company traded hands. The stock has a 50 day moving average of $64.31 and a 200-day moving average of $70.03. Amsurg Corp. has a 1-year low of $57.32 and a 1-year high of $84.71. The stock has a market capitalization of $3.62 billion, a price-to-earnings ratio of 20.80 and a beta of 0.67.

Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings results on Tuesday, November 1st. The company reported $1.13 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.13. Amsurg Corp. had a net margin of 6.06% and a return on equity of 8.05%. The firm had revenue of $822.20 million for the quarter, compared to analysts’ expectations of $770.29 million. During the same quarter last year, the company earned $1.03 EPS. The firm’s revenue for the quarter was up 26.5% compared to the same quarter last year. On average, equities analysts anticipate that Amsurg Corp. will post $4.31 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/29/amsurg-corp-amsg-stake-decreased-by-state-of-wisconsin-investment-board.html.

A number of equities analysts recently weighed in on AMSG shares. Cantor Fitzgerald set a $90.00 target price on shares of Amsurg Corp. and gave the stock a “buy” rating in a research report on Wednesday, November 2nd. KeyCorp reaffirmed a “positive” rating and set a $87.00 price target on shares of Amsurg Corp. in a research note on Tuesday, October 4th. Zacks Investment Research downgraded shares of Amsurg Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Citigroup Inc. initiated coverage on shares of Amsurg Corp. in a research note on Monday, September 26th. They set a “buy” rating and a $79.00 price target on the stock. Finally, Mizuho downgraded shares of Amsurg Corp. from a “buy” rating to a “neutral” rating and decreased their price target for the company from $95.00 to $71.00 in a research note on Wednesday, November 9th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Amsurg Corp. has an average rating of “Buy” and an average target price of $89.45.

About Amsurg Corp.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

5 Day Chart for NASDAQ:AMSG

Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.